A wide spectrum of focal, regional, or diffuse structural brain abnormalities, collectively known as malformations of cortical development (MCDs), frequently manifest with intellectual disability (ID), epilepsy, and/or autistic spectrum disorder (ASD). As the acronym suggests, MCDs are perturbations of the normal architecture of the cerebral cortex and hippocampus. The pathogenesis of these disorders remains incompletely understood; however, one area that has provided important insights has been the study of neuronal migration. The amalgamation of human genetics and experimental studies in animal models has led to the recognition that common genetic causes of neurodevelopmental disorders, including many severe epilepsy syndromes, are due to mutations in genes regulating the migration of newly born post-mitotic neurons. Neuronal migration genes often, though not exclusively, code for proteins involved in the function of the cytoskeleton. Other cellular processes, such as cell division and axon/dendrite formation, which similarly depend on cytoskeletal functions, may also be affected. We focus here on how the susceptibility of the highly organized neocortex and hippocampus may be due to their laminar organization, which involves the tight regulation, both temporally and spatially, of gene expression, specialized progenitor cells, the migration of neurons over large distances and a birthdate-specific layering of neurons. Perturbations in neuronal migration result in abnormal lamination, neuronal differentiation defects, abnormal cellular morphology and circuit formation. Ultimately this results in disorganized excitatory and inhibitory activity leading to the symptoms observed in individuals with these disorders.
Human neuronal migration disorders

Type I lissencephaly
The prototype of a so-called 'neuronal migration disorder' is lissencephaly, which literally means "smooth brain" (derived from Ancient Greek). Type I, also known as classical lissencephaly, consists of a group of related neuronal migration disorders. Included in this spectrum are agyric (without gyri), pachygyric (simplified gyri) and subcortical band heterotopic (abnormally positioned neurons, SBH) forms (Barkovich et al., 2012; Francis et al., 2006) . Patients with severe type I lissencephaly exhibit ID and epilepsy, the latter often pharmacoresistant. Post-mortem studies of lissencephalic brains have identified at least four patterns of cortical disorganization (Forman et al., 2005) . The most commonly observed shows the replacement of the normal six layer neocortex with a markedly thickened four layer cortex (Forman et al., 2005) . Pathologic review of these brains suggests a roughly inverted cortex with large pyramidal neurons normally found in layer 5 appearing superficially, just below the molecular layer (layer 1) to form an abnormal layer 2. Below this layer, forming a very thick (up to several centimeters) layer 4 that extends down to the white matter, is a disorganized collection of neurons, believed to normally populate layers 2-4. Intercalated between the layer of pyramidal neurons and the deep layer of smaller neurons is a relatively cell sparse layer that appears by early childhood, representing layer 3. Although the gyral pattern is severely affected, in most cases the brain appears to be normal size at birth; however, postnatal microcephaly is often associated with agyric cases (Pavone et al., 1993) . Pachygyria is associated with a similarly disorganized cortex, although the presence of large simplified gyri suggests a different (potentially better) organization of neurons in some regions compared to agyria. The characteristics of different types of human MCDs and associated genes are described below and summarized in Table 1 .
The study of families with single and multiple affected individuals aided the discovery of a number of type I lissencephaly genes, often related to the microtubule cytoskeleton. The first to be identified was lissencephaly 1 (LIS1) (Reiner et al., 1993) . Mutations in LIS1 (PAFAH1B1, platelet-activating factor acetylhydrolase 1b, regulatory subunit 1), along with mutations in doublecortin (DCX) (des Portes Neurobiology of Disease 92 (2016) 18-45 
